- FINTEPLA® (fenfluramine) | Official Patient Website
FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
- Homepage | Fintepla HCP
Learn about FINTEPLA®, a treatment for seizures associated with Dravet syndrome and LGS, and get full Prescribing Information, including Boxed Warning
- Fenfluramine - Wikipedia
Fenfluramine, sold under the brand name Fintepla, is a serotonergic medication used for the treatment of seizures associated with Dravet syndrome and Lennox–Gastaut syndrome [2][6][3] It was formerly used as an appetite suppressant in the treatment of obesity, but was discontinued for this use due to cardiovascular toxicity before being
- label - accessdata. fda. gov
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older
- Fintepla: Package Insert Prescribing Information MOA
Fintepla package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
- Fintepla (fenfluramine) - Uses, Side Effects, and More
Find patient medical information for Fintepla (fenfluramine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Fintepla® | UCB
In the European Union and in the UK, Fintepla ® is indicated for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older
|